Open Access

Neuroprotective effects of hydrogen sulfide on sodium azide-induced oxidative stress in PC12 cells

  • Authors:
    • Cheng Gao
    • Pan Chang
    • Lijun Yang
    • Yi Wang
    • Shaohua Zhu
    • Haiyan Shan
    • Mingyang Zhang
    • Luyang Tao
  • View Affiliations

  • Published online on: November 1, 2017
  • Pages:242-250
  • Copyright: © Gao et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: HTML 0 views | PDF 0 views     Cited By (CrossRef): 0 citations


Alzheimer's disease (AD) is the most common neurodegenerative disorder, responsible for >50% of all dementia cases. Sodium azide (NaN3) inhibits cytochrome oxidase by irreversibly binding to the heme cofactor and selectively reducing the complex IV activity, which is present in post‑mortem AD brains. Previous data demonstrated that hydrogen sulfide (H2S), the third endogenous gaseous mediator, exerted protective effects against neuronal damage. Therefore, it was hypothesized that H2S may be able to scavenge excess reactive oxygen species (ROS), thereby protecting against oxidative stress and cell death. In the present study, it was observed that cell viability decreased in a concentration-dependent manner 12 h after NaN3 treatment (20, 30 and 50 mmol/l). A decrease in cell viability (to 51±3%) was observed 12 h after treatment with 30 mM NaN3. NaN3 treatment also led to decreased mitochondrial membrane potential, increased lipid peroxidation (excessive production of malondialdehyde), and increased the protein expression levels of caspase-3. Pretreatment with H2S (200 µmol/l) attenuated NaN3-mediated apoptosis, and the anti-apoptotic action of H2S was partially dependent on suppressing the production of ROS. The findings of the present study suggested that H2S exerted a neuroprotective effect against NaN3-induced neurotoxicity through mechanisms related to anti-oxidation and anti-apoptosis. Therefore, the findings of the present study suggest there may be a promising future for H2S-based preventions and therapies for neuronal damage following exposure to NaN3.


Alzheimer's disease (AD) is a neurodegenerative disorder, accounting for 50–70% of all dementia cases and affecting >12 million individuals worldwide. AD is an age-related neurodegenerative illness characterized by a progressive decline in cognitive functions, and histopathologically by the presence of neuritic plaques containing amyloid-β (Aβ) peptide and neurofibrillary tangles, mostly constisting of hyperphosphorylated Tau protein (1). AD exists in familial (early- and late-onset) forms, as well as a sporadic form, which is very common, accounting for ~90% of all cases. AD has a complex multietiological origin; however, its exact genetic and environmental causative factors are unknown. Increasing evidence indicates that different processes contribute to neurodegeneration, including mitochondrial dysfunction, oxidative stress and impairment of the autophagic/lysosomal/endosomal system (2,3). Numerous studies have demonstrated that oxidative stress is one of the initiating events and one of the molecular changes underlying the pathogenesis of AD (4,5).

Oxidative stress may result from suppression of mitochondrial function. Cytochrome oxidase (COX) is a mitochondrial enzyme that plays an important role in aerobic energy metabolism and mitochondrial function. Mitochondrial abnormalities, particularly of COX, are found in the brains of subjects with AD (6). The principal toxic action of sodium azide (NaN3) is inhibiting the function of COX in the mitochondrial electron transport chain (7). The model of brain mitochondrial COX inhibition by NaN3 was described in rats in an attempt to mimic the morphological and behavioral pathology of AD (8). The involvement of mitochondrial dysfunction and the consequent overproduction of reactive oxygen species (ROS) is increasingly recognized and widely accepted as an etiopathological factor of AD. The tissue-specific inhibition of COX by NaN3 may serve as a useful tool for the evaluation of AD in vivo and in vitro.

Hydrogen sulfide (H2S), is considered as the third most abundant endogenous signaling gasotransmitter following nitric oxide (NO) and carbon monoxide, which affects physiological and pathophysiological processes in a wide range of biological systems (9). H2S is produced endogenously in mammals, including humans. In particular, cystathionine-β-synthase (CBS) in the central nervous system (CNS) and cystathionine-γ-lyase in the cardiovascular system are the key enzymes that are mainly responsible for the endogenous generation of H2S (10). 3-Mercaptopyruvate sulfurtransferase (3- MST) is also known to be a significant producer of endogenous H2S in the brain (11). Increasing evidence demonstrates that H2S is associated with AD pathogenesis (12). The dysfunction of CBS in the transsulfuration pathway may lead to a decrease in H2S production in AD (13). Interestingly, the levels of H2S are severely decreased in AD patients; moreover, plasma H2S levels are negatively correlated with the severity of the disease in AD patients (14). Moreover, our previous research demonstrated downregulation of the expression and activity of CBS and 3-MST in neuron-like rat pheochromocytoma (PC12) cells induced by NaN3 (data not shown). However, it is not known whether H2S has any therapeutic benefits in AD. Therefore, the present study was undertaken to assess the beneficial effects of sodium hydro-sulfide (NaHS), which is an exogenous H2S donor, on the underlying cellular and molecular mechanisms in neuronal cells treated with NaN3.

The characteristics of neuronal damage induced by NaN3 treatment were first investigated. The neuroprotective activity of H2S and its effect on oxidative stress were also investigated in PC12 cells with neuronal damage induced by NaN3. To the best of our knowledge, this is the first study to demonstrate that H2S can suppress NaN3-induced oxidative stress and apoptosis in PC12 cells. This study was conducted to gain better insight into the physiological functions of H2S under normal and injury conditions, and its association with the cellular and molecular mechanisms underlying nervous system disease.

Materials and methods

Cell culture

Rat pheochromocytoma PC12 cells were obtained from the Shanghai Institute of Cell Biology, Chinese Academy of Sciences (Shanghai, China). PC12 cells were grown on polystyrene tissue culture dishes in DMEM containing 10% horse serum and 5% fetal bovine serum (FBS; Sijiqing Biological Engineering Materials Co., Ltd., Hangzhou, China), supplemented with 2 mmol/l glutamine, 100 μg/ml streptomycin, and 100 U/ml penicillin (Gibco; Thermo Fisher Scientific, Inc., Waltham, MA, USA) at 37°C with 95% air, 5% CO2. Prior to differentiation, the medium was exchanged twice a week and the cultures were subcultured at a ratio of 1:4 once a week. For differentiation, the cells were washed and incubated in a fresh medium containing nerve growth factor (NGF; final concentration, 50 ng/ml) for 48 h at 37°C in a cell incubator. The concentration of NGF was maintained throughout all experiments. All the experiments were performed on cells between passages 3–8.

Cell injury model

The injury model was constructed as follows: briefly, the DMEM was removed, PC12 cells were washed twice with glucose-free Earle's balanced salt solution (EBSS) at pH 7.5, and maintained in glucose-free DMEM without FBS. Subsequently, neurotoxic damage was induced by adding the indicated concentration of NaN3 to the cultured cells for different periods of time. The cells were preincubated with the indicated concentrations of NaHS (donor of H2S) for 30 min prior to NaN3 treatment and maintained throughout the entire experiment. NaHS was dissolved in saline and was freshly prepared immediately prior to use. The stock solutions were directly added into the bath solution to achieve the final concentration. Control cultures were maintained in DMEM for the same duration under normoxic conditions. The concentrations of all the reagents were maintained throughout the injury period.

Determination of cell viability

The viability of PC12 cells was determined using the Cell Counting Kit-8 (CCK-8) assay (Dojindo Molecular Technologies, Inc., Kumamoto, Japan), according to the manufacturer's instructions. PC12 cells were cultured in 96-well plates at 37°C under an atmosphere of 5% CO2 and 95% air. At the end of treatment, CCK-8 reagent (10 μl) was added to each well and the plates were then incubated at 37°C for 3 to 4 h in the incubator. Absorbance at a wavelength of 450 nm was measured with a microplate reader (BioTek Instruments, Inc., Winooski, VT, USA). The means optical density (OD) from 6 wells in the indicated groups were used to calculate the cell viability, which was expressed as a percentage of cell survival rate compared with the control. All the experiments were performed in triplicate and repeated three independent times.

Determination of mitochondrial membrane potential (MMP)

MMP was examined by staining PC12 cells with JC-1. Staining was performed using 2.5 mg/ml JC-1 at 37°C for 15 min. After staining, cells were rinsed three times with phosphate-buffered saline (PBS). A confocal laser scanning microscope was used to measure MMP using the JC-1 assay kit (C2006; Beyotime Institute of Biotechnology, Haimen, China). Under the microscope, images of different color were obtained. Green fluorescence indicated cells with low MMP (Δψm), revealing that JC-1 maintains (or reacquires) monomeric form, while red fluorescence indicated cells with high Δψm. The relative proportions of red and green fluorescence were used to measure the extent of mitochondrial depolarization.

Intracellular ROS measurement

Production of intracellular ROS was determined using the fluorescent probe dichlorofluorescin diacetate (DCFH-DA), which can cross cell membranes and is subsequently hydrolyzed by intracellular esterase to non-fluorescent DCFH (Beyotime Institute of Biotechnology). Following treatment with NaN3 for 12 h in the presence or absence of 200 mM H2S, the culture medium was changed to fresh DMEM containing 10 μM DCFH-DA for 30 min in an incubator at 37°C in the dark. After washing three times with PBS, the cells were observed under a fluorescence spectrophotometer with an excitation wavelength of 488 nm and an emission wavelength of 535 nm.

Measurement of lipid peroxidation

Malondialdehyde (MDA), a terminal product of lipid peoxidation, was measured to estimate the extent of lipid peoxidation in PC12 cells. The cells were then homogenized in lysis buffer [1% NP-40, 50 mmol/l Tris, pH 7.5, 5 mmol/l EDTA, 1% sodium dodecyl sulphate (SDS), 1% sodium deoxycholate, 1% Triton X-100, 1 mmol/l phenylmethanesulfonylfluoride, 10 μg/ml aprotinin, and 1 μg/ml leupeptin] and clarified by centrifuging for 20 min in a microcentrifuge at 4°C. MDA concentration in cell homogenates was determined with an MDA assay kit (S0131; Beyotime Institute of Biotechnology), using the thiobarbituric acid method. The assay was based on the ability of MDA to form a conjugate with thiobarbituric acid and create a red product, which has maximum absorbance at 532 nm.

Western blot analysis

The cells were then homogenized in lysis buffer (1% NP-40, 50 mmol/l Tris, PH 7.5, 5 mmol/l EDTA, 1% SDS, 1% sodium deoxycholate, 1% Triton X-100, 1 mmol/l phenylmethanesulfonylfluoride, 10 μg/ml aprotinin, and 1 μg/ml leupeptin) and clarified by centrifuging for 20 min in a microcentrifuge at 4°C. Following determination of its protein concentration with the Bradford assay (Bio-Rad Laboratories, Inc., Hercules, CA, USA), the resulting supernatant (50 μg of protein) was subjected to SDS polyacrylamide gel electrophoresis. The separated proteins were transferred to a polyvinylidine difluoride membrane (Millipore, Billerica, MA, USA) by a transfer apparatus at 90V for 1 h. The membrane was then blocked with 5% non-fat milk and incubated with primary antibody against caspase-3 (1:500, cat. no. BS1518) and Bcl-2 (1:500, cat. no. BZ00479) (both from Bioworld Technology, Inc., St. Louis Park, MN USA) or GAPDH (1:1,000, cat. no. G8795; Sigma-Aldrich; Merck KGaA, St. Louis, MO, USA). After incubating with an anti-rabbit or anti-mouse horseradish peroxidase-conjugated secondary antibody, protein was visualized using an enhanced chemiluminescence system (ECL; cat. no. 32106; Pierce; Thermo Fisher Scientific, Inc., Bellefonte, PA, USA).

Immunofluorescence analysis

Immunofluorescence analysis was performed as follows: the PC12 cell in a 24-well plate were fixed with 4% paraformaldehyde for 15 min at room temperature and washed with PBS three times, for 10 min each time. After the cells were prepared, they were blocked with 5% donkey serum (Gibco; Thermo Fisher Scientific, Inc.) with 0.3% Triton X-100 and 5% bovine serum albumin (BSA) for 2 h at room temperature and incubated with rabbit polyclonal primary anti-caspase-3 antibodies (1:50, cat. no. ab13847; Abcam, Cambridge, UK). Briefly, the cells were incubated with the primary antibodies overnight at 4°C, followed by a mixture of fluorescein isothiocyanate-conjugated secondary antibodies for 2 h at room temperature, then washed with PBS three times, for 10 min each time. Finally, the samples were mounted with coverslips using antifade mounting medium (Beyotime Institute of Biotechnology) and observed under a fluorescence microscope (Eclipse Ti-S; Nikon, Tokyo, Japan). At least three random slides from each group were examined.

Statistical analysis

All statistical analyses were conducted with SPSS statistical software 16.0 (SPSS, Inc., Chicago, IL, USA). All the values are expressed as means ± standard error of the mean. The statistical significance of differences between groups was determined by one-way analysis of variance followed by Tukey's post hoc multiple comparison tests or Student's t-test (two means comparison). P<0.05 was considered to indicate statistically significant differences. Each experiment consisted of at least three replicates per condition.


NaN3 is cytotoxic to PC12 cells

Cell cytoxicity was evaluated by the CCK-8 assay following incubation of PC12 cells with increasing concentrations of NaN3 from 5 to 100 mmol/l at 1, 3, 6, 12, 18 and 24 h. As shown in Fig. 1A, at concentrations of 5–100 mmol/l, treatment of PC12 cells with NaN3 for 12 h led to a concentration-dependent reduction in cell viability. The results demonstrated that the general trend of cell survival rate decreased with increasing treatment time (Fig. 1B).

H2S protects PC12 cells against NaN3-induced cytotoxicity

To investigate the effect of H2S on NaN3-induced cytotoxicity, cell viability was analyzed by determining the percentage of CCK-8 reduction. As shown in Fig. 2, treatment with NaN3 at concentrations of 30 mmol/l for 12 h attenuated cell viability. The cytotoxic effects of NaN3 on PC12 cells were significantly prevented by pretreatment with NaHS at 100–200 μmol/l for 30 min. At 200 μmol/l, NaHS alone did not measurably affect the viability of PC12 cells.

H2S exerts a protective effect against NaN3-induced dissipation of the mitochondrial membrane potential

To confirm that NaN3 induced a mitochondrial membrane potential reduction in PC12 cells, laser microscopy was used to visualize the fluorescence dye-stained mitochondria. When PC12 cells were exposed to NaN3, the mitochondrial membrane rapidly depolarized, as shown by the increase in green fluorescence (Fig. 3C). Pretreatment with NaHS reduced the changes in mitochondrial membrane potential, as indicated by repression of green fluorescence and restoration of red fluorescence (Fig. 3D). The quantitative analysis of the red/green ratios also demonstrated the protective role of H2S in NaN3-induced a mitochondrial membrane potential reduction (Fig. 3E).

H2S reduces NaN3-induced intracellular ROS accumulation in PC12 cells

The mitochondrion is considered to be the main site of ROS production, and an increased ROS level within the cell reflects mitochondrial dysfunction. Therefore, the effect of H2S on ROS levels was investigated. N-acetyl-L-cysteine (NAC) is commonly used to identify and test ROS inducers and to inhibit ROS as a positive control. Intracellular ROS accumulation may be measured by the use of DCF-DA, which freely crosses the cell membrane. Once inside the cells, the compound is hydrolyzed by cellular esterase to DCF, which interacts with peroxides forming fluorescent 2′,7′-dichlorofluorescin. PC12 cells treated with NaN3 displayed intense fluorescence after staining with DCF dye (Fig. 4C). Intracellular ROS accumulation resulting from NaN3 treatment was significantly reduced when H2S (Fig. 4D) or NAC (Fig. 4E) was present in the medium.

H2S attenuates NaN3-induced lipid peroxidation increase in PC12 cells

When PC12 cells were exposed to NaN3 (30 mmol/l) for 12 h, an increase in the lipid peroxidation level, as indicated by the excessive formation of MDA in PC12 cells, was observed to 150% of control values (Fig. 5). Pretreatment with H2S at concentrations of 200 μmol/l significantly decreased lipid peroxidation (decrease in the formation of MDA) compared with the levels observed in the NaN3 group.

H2S suppresses NaN3-induced apoptosis in PC12 cells

To certify the effects of H2S on NaN3-induced apoptosis, the following studies were performed: caspase-3 is a critical marker of apoptosis. To determine the effects of NaN3 on cell apoptosis and the response of H2S to the effects of NaN3, the levels of caspase-3 and Bcl-2 expression were measured by western blot analysis. As illustrated in Fig. 6, 12-h treatment with NaN3 (30 mmol/l) significantly increased the amount of caspase-3 expression (Fig. 6B), but decreased Bcl-2 expression (Fig. 6C). However, co-treatment with 200 μmol/l NaHS for 12 h significantly abolished the NaN3-induced decrease in Bcl-2 expression and increase in caspase-3 expression. These results indicate that H2S is able to block the NaN3-elicited downregulation of Bcl-2 expression and upregulation of caspase-3 expression. In addition, we observed the effect of NaHS on autophagic cell death in PC12 cells treated with NaN3 by caspase-3 staining. As shown in Fig. 7, at 12 h after treatment with NaN3 (30 mmol/l), the number of caspase-3-positive cells observably increased. Co-treatment with NaHS (200 μmol/l) significantly ameliorated the NaN3-induced increase of caspase-3-positive cells. The control and NaHS-treated groups displayed few caspase-3-positive cells.


Endogenous H2S may have multiple physiological functions in the brain. Our previous study demonstrated that H2S improved spatial memory impairment and alleviated cerebral edema in traumatic brain injury (TBI) mice (15,16). A number of epidemiological studies provided compelling evidence that sustaining a TBI is associated with increased risk for degenerative conditions that may result in dementia, including AD; however, several of the underlying mechanisms have yet to be fully elucidated. A complex disease such as AD involves multiple interwoven pathways leading to neuronal damage, whereas increasing evidence suggests that oxidative stress is one of the initiating events (17,18). The aim of the present study was to examine the cell damage occurring in cultured PC12 cells when exposed to NaN3. Due to its ability to induce oxidative stress through inhibition of the electron transfer between COX and oxygen, this model represents an interesting tool in neurotoxicity studies. However, to the best of our knowledge, no study to date has investigated whether H2S can prevent cytotoxicity induced by NaN3 in PC12 cells, and whether oxidative stress plays an important role in NaN3-induced apoptosis. In the present study, the possible molecular mechanisms underlying the neuroprotective effects of H2S against NaN3-induced neuron cell injury were investigated. Furthermore, we investigated the connection between the generation of ROS and the activity of caspase-3 in NaN3-induced apoptosis in PC12 cells and demonstrated a concentration- and time-dependent reduction of cell viability induced by NaN3. Our findings demonstrated that NaHS, a H2S donor, attenuated NaN3-mediated apoptosis, and the anti-apoptotic action of H2S was partly dependent on suppressing the production of ROS and inhibition of caspase-3 activity, and was associated with increasing the expression of the anti-apoptotic protein Bcl-2.

AD is a multifactorial neurodegenerative disorder. Among the numerous contributing factors, cellular stress and, in particular, oxidative stress, have attracted considerable attention, as several studies reported its involvement in AD pathogenesis (19,20). The evidence of oxidative damage in the postmortem AD brain is quite compelling, with significant accumulation of markers of oxidative damage of lipids, proteins and DNA, increased accumulation of transition metals, such as Fe, Cu and Zn, as well as impaired antioxidant defense (21). The recent redox proteomics analysis of the postmortem AD brain has demonstrated oxidative damage to key enzymes involved in energy metabolism, neurotransmitter-related proteins, mitochondrial proteins and proteasomal components (22). Multiple lines of evidence indicate that oxidative stress is an early event in AD, occurring prior to cytopathological changes, and may therefore play a key pathogenic role in the disease (20,23). Oxidative stress is the production of ROS in amounts exceeding the ability of the body's antioxidant systems to counteract their effects (24). These free radical species, which contain one or more unpaired electrons, act as electron donors, causing oxidation that potentially leads to damage of body macromolecular polymers, such as lipids, proteins and nucleic acids (25). The most important of all cell targets of ROS are nervous system cells, particularly neurons, which are highly susceptible to the harmful effects of ROS (26).

NaN3, as a COX inhibitor, has been extensively considered as a useful tool to study different pathological conditions. Mitochondrial energy metabolism is suggested to be a determining element for interpreting impaired neuron function, reduced molecular turnover, and enhanced cell death (27,28). Inhibition of mitochondrial COX has been found to induce cell death in a variety of cells. Sato et al reported that SCC131 cells died 48–72 h after NaN3 treatment at concentrations more than 5 mM (29). Lutton et al reported that NaN3 treatment at a concentration of 1 mM induced necrosis in rat osteoclasts (30). In those studies, the longest treatment time required to induce cell death was more than 24 h. The reason for this finding may be differences between the types of cells, specifically differential sensitivity of the excretory function or the detoxification function, and the quantity of the mitochondria of the target cells. PC12 cells, which are generally considered to display neuronal-like characteristics, appear to be more sensitive to NaN3. To induce oxidative stress in PC12 cells, NaN3 concentrations ranged from 1 to 10 mM in several experiments (31,32). Wang et al reported that the viability of PC12 cells treated with 64 mM NaN3 for 4 h decreased by 47.8% (33). Zhang et al reported that cultured PC12 cells was incubated with NaN3 20 mM for 3–24 h to induce apoptosis (34). Increased autophagy was also observed in multiple and distinct experimental injury models (35,36). We tested the 5-mM concentration of NaN3 at 36 h. Although the result of the cell viability assay revealed that NaN3 induced cell death, autophagic cell death was not observed under these conditions. However, it is not known whether the role of autophagy is protective or detrimental for neural cell injury. It is possible that the role of autophagy after cell injury is dependent upon the cell's capacity to respond to the cumulative burden of damaged or dysfunctional macromolecules and organelles. If the increase in autophagic capacity is insufficient, augmenting autophagy would likely be beneficial. When there is excessive increase in autophagic capacity, inhibiting autophagy may be beneficial. Thus, the role of autophagy may be dictated by whether it is able to meet intracellular demands. The cell viability data were important in order to evaluate whether cells were still physiologically responsive, or if they were likely to be entering the cell death process. Therefore, the overall toxic effects of NaN3 was evaluated by monitoring cell viability in PC12 cells. In order to induce cell death in PC12 cells, high concentrations of NaN3 (30 mM) were applied in our experiments. Under these more severe stress conditions, when PC12 cell viability is already severely hampered, an accumulation of autophagic cell death was observed (37). A future study is planned to focus mainly on autophagic cell death in PC12 cells induced by NaN3.

Mitochondrial dysfunction induced by NaN3 provides a common platform for investigating the mechanisms of neuronal injury, which may prove useful for screening potential protective agents against neuronal death (38). Hyperoside has the neuroprotective capacity to attenuate NaN3-induced apoptosis in PC12 cells (34). Wang et al reported that aloe vera extract exerted a protective effect against mitochondrial functional impairment induced by NaN3 in PC12 cells (33). H2S has increasingly been recognized as a gasotransmitter of comparable importance to nitric oxide and carbon monoxide in mammalian systems. Evidence suggests that these gasotransmitters are involved in the origin of life and play key roles in the endosymbiotic events that contribute to the biogenesis and development of mitochondria. In addition to its function as a signaling molecule, H2S also acts as a cytoprotectant in neurons and cardiac muscle (11). The neuroprotective properties of H2S have long been observed, leading to extensive research that has been widely reported and continues to attract interest (39). In a rat model, it was demonstrated that H2S exerts a protective effect and diminishes oxidative stress and homocysteine-induced toxicity by its antioxidant properties in the adrenal medulla and smooth muscle cells of the vesicles (40). This raises the possibility of H2S being a possible therapeutic strategy in the treatment of neurodegenerative disorders. To investigate whether ROS are involved in NaN3-induced injury, PC12 cells were pretreated with NAC (a ROS scavenger) prior to exposure to NaN3. The cell viability data were important in order to evaluate if cells remained physiologically responsive, or if they were likely to be entering cell death. We observed that NaN3 induced not only ROS production, but also initiated injury of PC12 cells, including a decrease in cell viability, loss of MMP and caspase-3 activation, as well as an increase in the number of apoptotic cells. These effects were significantly prevented by NAC pretreatment, indicating that NaN3-induced neuronal injury is due to its induction of ROS. Exogenously applied free H2S is immediately absorbed in a sulfur store as bound sulfane sulfur (41). H2S may be transiently stored and then released when the cells are stimulated. H2S is absorbed in brain homogenates more slowly compared with liver and heart homogenates, and the release from brain homogenates is also slower compared with that from liver and heart homogenates (41,42). Once H2S is released from bound sulfane sulfur or from H2S-producing enzymes, free H2S may remain longer in the brain compared with the liver and the heart. Therefore, considering the slow absorption of H2S in the brain, pretreatment with NaHS was selected. Interestingly, it was observed that NaHS (a donor of H2S) shared similar neuroprotective properties with NAC with a comparable potency in this experimental model. This may support the ability of H2S in: i) inhibiting NaN3-mediated protein cytotoxicity; ii) inhibiting NaN3-mediated oxidative damage; and iii) inhibiting generation of ROS induced by NaN3.

H2S is synthesized in a number of different cell types and can easily diffuse without involvement of any transporters. H2S is involved in a number of organ-specific functions, such as thermoregulation, modulating myocardial activity and bronchodilation (43). H2S also exerts organ-protective effects in ischaemia, acting as a vasodilator and negative inotrope to reduce blood pressure (44). A number of studies have investigated the possible benefit of H2S in hypertension, and found that H2S donor administration significantly reduced blood pressure and oxidative stress in hypertensive mice (45,46). H2S has also been found to play a role in the pathology and treatment of chronic obstructive pulmonary disease. Exogenously supplied H2S may counteract the oxidative stress-mediated lung damage that occurs in allergic mice (47). Low H2S levels have been observed in a number of different diseases, while there is evidence that H2S may be beneficial in a number of chronic organ degenerative conditions. Chronic kidney disease is associated with a significant reduction in plasma H2S concentration, and H2S may ameliorate adenine-induced chronic renal failure in rats by inhibiting apoptosis through ROS signaling pathways (48). Diabetes is a chronic metabolic disease affecting the metabolism of carbohydrates and other nutrients. H2S protects against the development of hyperglycemia-induced endothelial dysfunction by attenuating the hyperglycemia-induced enhancement of ROS formation (49). As regards degenerative diseases of the CNS, H2S treatment can specifically inhibit 6-OHDA-evoked NADPH oxidase activation and oxygen consumption in Parkinson's disease (50). Moreover, H2S protects neurons against oxidative stress, which is responsible for neuronal damage and degeneration in AD (51). In conclusion, H2S donors have consistently been shown to be beneficial in acute organ injury and in chronic organ pathology through ROS signaling pathways. More specifically, data available thus far strongly suggest that H2S may be a potent preventive and therapeutic agent used for the prevention and improvement of the symptoms of oxidative stress-associated diseases, which is worthy of further investigation in future studies.

Although H2S exhibited promising efficacy in NaN3-mediated cell injury, research is still underway to identify selective oxidative stress regulators as potential treatment drugs. In summary, the evidence presented herein indicates an actively protective role for H2S against oxidative stress and apoptosis induced by NaN3. Our data may provide a novel pathway to elucidate the underlying molecular and cellular mechanisms in the CNS following inhibition of COX, and a novel strategy for the treatment of CNS diseases. Future studies attempting to characterize the functional consequences of H2S under conditions of oxidative stress and the identification of substrates and downstream signaling targets are now possible. Other H2S donors, such as drug-like H2S donor ATB-346 or orally active H2S donor SG-1002, may be used to evaluate the protective effect of H2S in injury models in the future. Testing these drug-like H2S donors will not only consolidate the protective effect of H2S, but also shed light on the clinical application of H2S as a therapeutic agent.


The present study was supported by the National Natural Science Foundation of China (grant nos. 81601306, 81301039 and 81530062); the China Postdoctoral Science Foundation Funded Project (grant no. 2015M570476); the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); the Jiangsu Talent Youth Medical Program (grant no. QNRC2016245); the Key Laboratory of Evidence Science (China University of Political Science and Law), Ministry of Education (grant no. 2016KFKT05); the Shanghai Key Laboratory of Forensic Medicine (grant no. KF1502); and the Suzhou Science and Technology Development Project (grant no. SYSD2015119).



Takahashi RH, Nagao T and Gouras GK: Plaque formation and the intraneuronal accumulation of β-amyloid in Alzheimer's disease. Pathol Int. 67:185–193. 2017. View Article : Google Scholar : PubMed/NCBI


Martinez-Vicente M: Neuronal mitophagy in neurodegenerative diseases. Front Mol Neurosci. 10:642017. View Article : Google Scholar : PubMed/NCBI


Menzies FM, Fleming A, Caricasole A, Bento CF, Andrews SP, Ashkenazi A, Füllgrabe J, Jackson A, Jimenez Sanchez M, Karabiyik C, et al: Autophagy and neurodegeneration: pathogenic mechanisms and therapeutic opportunities. Neuron. 93:1015–1034. 2017. View Article : Google Scholar : PubMed/NCBI


Cai Q and Tammineni P: Alterations in mitochondrial quality control in Alzheimer's disease. Front Cell Neurosci. 10:242016. View Article : Google Scholar : PubMed/NCBI


Cai Q and Tammineni P: Mitochondrial aspects of synaptic dysfunction in Alzheimer's disease. J Alzheimers Dis. 57:1087–1103. 2017. View Article : Google Scholar


Cadonic C, Sabbir MG and Albensi BC: Mechanisms of mitochondrial dysfunction in Alzheimer's disease. Mol Neurobiol. 53:6078–6090. 2016. View Article : Google Scholar : PubMed/NCBI


Bennett MC, Mlady GW, Kwon YH and Rose GM: Chronic in vivo sodium azide infusion induces selective and stable inhibition of cytochrome c oxidase. J Neurochem. 66:2606–2611. 1996. View Article : Google Scholar : PubMed/NCBI


Weinstock M and Shoham S: Rat models of dementia based on reductions in regional glucose metabolism, cerebral blood flow and cytochrome oxidase activity. J Neural Transm (Vienna). 111:347–366. 2004. View Article : Google Scholar


Huang CW and Moore PK: H2S synthesizing enzymes: biochemistry and molecular aspects. Handb Exp Pharmacol. 230:3–25. 2015. View Article : Google Scholar


Kimura H: Hydrogen sulfide and polysulfides as biological mediators. Molecules. 19:16146–16157. 2014. View Article : Google Scholar : PubMed/NCBI


Kimura H: Hydrogen sulfide: its production, release and functions. Amino Acids. 41:113–121. 2011. View Article : Google Scholar


Liu Y, Deng Y, Liu H, Yin C, Li X and Gong Q: Hydrogen sulfide ameliorates learning memory impairment in APP/PS1 transgenic mice: a novel mechanism mediated by the activation of Nrf2. Pharmacol Biochem Behav. 150–151:207–216. 2016. View Article : Google Scholar


Dwyer BE, Raina AK, Perry G and Smith MA: Homocysteine and Alzheimer's disease: a modifiable risk. Free Radic Biol Med. 36:1471–1475. 2004. View Article : Google Scholar : PubMed/NCBI


Wei HJ, Li X and Tang XQ: Therapeutic benefits of H2S in Alzheimer's disease. J Clin Neurosci. 21:1665–1669. 2014. View Article : Google Scholar : PubMed/NCBI


Zhang M, Shan H, Chang P, Wang T, Dong W, Chen X and Tao L: Hydrogen sulfide offers neuroprotection on traumatic brain injury in parallel with reduced apoptosis and autophagy in mice. PLoS One. 9:e872412014. View Article : Google Scholar : PubMed/NCBI


Zhang M, Shan H, Wang T, Liu W, Wang Y, Wang L, Zhang L, Chang P, Dong W, Chen X, et al: Dynamic change of hydrogen sulfide after traumatic brain injury and its effect in mice. Neurochem Res. 38:714–725. 2013. View Article : Google Scholar : PubMed/NCBI


Tayler H, Fraser T, Miners JS, Kehoe PG and Love S: Oxidative balance in Alzheimer's disease: relationship to APOE, Braak tangle stage, and the concentrations of soluble and insoluble amyloid-β. J Alzheimers Dis. 22:1363–1373. 2010. View Article : Google Scholar


Chauhan V and Chauhan A: Oxidative stress in Alzheimer's disease. Pathophysiology. 13:195–208. 2006. View Article : Google Scholar : PubMed/NCBI


Henriques AG, Domingues SC, Fardilha M, da Cruz e Silva EF and da Cruz e Silva OA: Sodium azide and 2-deoxy- D-glucose-induced cellular stress affects phosphorylation-dependent AbetaPP processing. J Alzheimers Dis. 7:201–212. 2005. View Article : Google Scholar


Zhu X, Raina AK, Lee HG, Casadesus G, Smith MA and Perry G: Oxidative stress signalling in Alzheimer's disease. Brain Res. 1000:32–39. 2004. View Article : Google Scholar : PubMed/NCBI


Butterfield DA, Swomley AM and Sultana R: Amyloid β-peptide (1-42)-induced oxidative stress in Alzheimer disease: importance in disease pathogenesis and progression. Antioxid Redox Signal. 19:823–835. 2013. View Article : Google Scholar :


Butterfield DA, Di Domenico F, Swomley AM, Head E and Perluigi M: Redox proteomics analysis to decipher the neurobiology of Alzheimer-like neurodegeneration: overlaps in Down's syndrome and Alzheimer's disease brain. Biochem J. 463:177–189. 2014. View Article : Google Scholar : PubMed/NCBI


Petersen RB, Nunomura A, Lee HG, Casadesus G, Perry G, Smith MA and Zhu X: Signal transduction cascades associated with oxidative stress in Alzheimer's disease. J Alzheimers Dis. 11:143–152. 2007. View Article : Google Scholar : PubMed/NCBI


Dringen R: Metabolism and functions of glutathione in brain. Prog Neurobiol. 62:649–671. 2000. View Article : Google Scholar : PubMed/NCBI


Gadalla MM and Snyder SH: Hydrogen sulfide as a gasotransmitter. J Neurochem. 113:14–26. 2010. View Article : Google Scholar : PubMed/NCBI


Dumont M and Beal MF: Neuroprotective strategies involving ROS in Alzheimer disease. Free Radic Biol Med. 51:1014–1026. 2011. View Article : Google Scholar


Ott M, Gogvadze V, Orrenius S and Zhivotovsky B: Mitochondria, oxidative stress and cell death. Apoptosis. 12:913–922. 2007. View Article : Google Scholar : PubMed/NCBI


Yin F, Boveris A and Cadenas E: Mitochondrial energy metabolism and redox signaling in brain aging and neurodegeneration. Antioxid Redox Signal. 20:353–371. 2014. View Article : Google Scholar :


Sato E, Suzuki T, Hoshi N, Sugino T and Hasegawa H: Sodium azide induces necrotic cell death in rat squamous cell carcinoma SCC131. Med Mol Morphol. 41:211–220. 2008. View Article : Google Scholar : PubMed/NCBI


Lutton JD, Moonga BS and Dempster DW: Osteoclast demise in the rat: physiological versus degenerative cell death. Exp Physiol. 81:251–260. 1996. View Article : Google Scholar : PubMed/NCBI


Amador FC and Henriques AG: Monitoring protein phosphatase 1 isoform levels as a marker for cellular stress. Neurotoxicol Teratol. 26:387–395. 2004. View Article : Google Scholar : PubMed/NCBI


Satpute R, Bhattacharya R, S Kashyap R, J Purohit H, Y Deopujari J, M Taori G and F Daginawala H: Antioxidant potential of Fagonia arabica against the chemical ischemia-induced in PC12 cells. Iran J Pharm Res. 11:303–313. 2012.PubMed/NCBI


Wang Y, Cao L and Du G: Protective effects of Aloe vera extract on mitochondria of neuronal cells and rat brain. Zhongguo Zhong Yao Za Zhi. 35:364–368. 2010.In Chinese. PubMed/NCBI


Zhang L, Cheng X and Hu J: Neuroprotective effects of hyperoside on sodium azide-induced apoptosis in PC12 cells. Chin J Nat Med. 9:450–455. 2011.


Smith CM, Chen Y, Sullivan ML, Kochanek PM and Clark RS: Autophagy in acute brain injury: feast, famine, or folly. Neurobiol Dis. 43:52–59. 2011. View Article : Google Scholar


Liu L, Sun T, Xin F, Cui W, Guo J and Hu J: Nerve growth factor protects against alcohol-induced neurotoxicity in PC12 cells via PI3K/Akt/mTOR pathway. Alcohol Alcohol. 52:12–18. 2017. View Article : Google Scholar


Shan H, Chu Y, Chang P, Yang L, Wang Y, Zhu S, Zhang M and Tao L: Neuroprotective effects of hydrogen sulfide on sodium azide-induced autophagic cell death in PC12 cells. Mol Med Rep. Aug 25–2017.Epub ahead of print. View Article : Google Scholar


Selvatici R, Previati M, Marino S, Marani L, Falzarano S, Lanzoni I and Siniscalchi A: Sodium azide induced neuronal damage in vitro: evidence for non-apoptotic cell death. Neurochem Res. 34:909–916. 2009. View Article : Google Scholar


Kimura H: Hydrogen sulfide: production, release, and functions. Nippon Yakurigaku Zasshi. 139:6–8. 2012.In Japanese. View Article : Google Scholar


Zhang Y, Tang ZH, Ren Z, Qu SL, Liu MH, Liu LS and Jiang ZS: Hydrogen sulfide, the next potent preventive and therapeutic agent in aging and age-associated diseases. Mol Cell Biol. 33:1104–1113. 2013. View Article : Google Scholar : PubMed/NCBI


Ishigami M, Hiraki K, Umemura K, Ogasawara Y, Ishii K and Kimura H: A source of hydrogen sulfide and a mechanism of its release in the brain. Antioxid Redox Signal. 11:205–214. 2009. View Article : Google Scholar


Kimura H: Hydrogen sulfide: from brain to gut. Antioxid Redox Signal. 12:1111–1123. 2010. View Article : Google Scholar


Yu XH, Cui LB, Wu K, Zheng XL, Cayabyab FS, Chen ZW and Tang CK: Hydrogen sulfide as a potent cardiovascular protective agent. Clin Chim Acta. 437:78–87. 2014. View Article : Google Scholar : PubMed/NCBI


Jin Z, Chan H, Ning J, Lu K and Ma D: The role of hydrogen sulfide in pathologies of the vital organs and its clinical application. J Physiol Pharmacol. 66:169–179. 2015.PubMed/NCBI


Al-Magableh MR, Kemp-Harper BK and Hart JL: Hydrogen sulfide treatment reduces blood pressure and oxidative stress in angiotensin II-induced hypertensive mice. Hypertens Res. 38:13–20. 2015. View Article : Google Scholar


Meng G, Ma Y, Xie L, Ferro A and Ji Y: Emerging role of hydrogen sulfide in hypertension and related cardiovascular diseases. Br J Pharmacol. 172:5501–5511. 2015. View Article : Google Scholar :


Benetti LR, Campos D, Gurgueira SA, Vercesi AE, Guedes CE, Santos KL, Wallace JL, Teixeira SA, Florenzano J, Costa SK, et al: Hydrogen sulfide inhibits oxidative stress in lungs from allergic mice in vivo. Eur J Pharmacol. 698:463–469. 2013. View Article : Google Scholar


Wu D, Luo N, Wang L, Zhao Z, Bu H, Xu G, Yan Y, Che X, Jiao Z, Zhao T, et al: Hydrogen sulfide ameliorates chronic renal failure in rats by inhibiting apoptosis and inflammation through ROS/MAPK and NF-κB signaling pathways. Sci Rep. 7:4552017. View Article : Google Scholar


Suzuki K, Olah G, Modis K, Coletta C, Kulp G, Gerö D, Szoleczky P, Chang T, Zhou Z, Wu L, et al: Hydrogen sulfide replacement therapy protects the vascular endothelium in hyperglycemia by preserving mitochondrial function. Proc Natl Acad Sci USA. 108:13829–13834. 2011. View Article : Google Scholar : PubMed/NCBI


Hu LF, Lu M, Tiong CX, Dawe GS, Hu G and Bian JS: Neuroprotective effects of hydrogen sulfide on Parkinson's disease rat models. Aging Cell. 9:135–146. 2010. View Article : Google Scholar : PubMed/NCBI


Kimura Y and Kimura H: Hydrogen sulfide protects neurons from oxidative stress. FASEB J. 18:1165–1167. 2004.PubMed/NCBI

Related Articles

Journal Cover

January 2018
Volume 41 Issue 1

Print ISSN: 1107-3756
Online ISSN:1791-244X

2016 Impact Factor: 2.341
Ranked #21/128 Medicine Research and Experimental
(total number of cites)

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
Gao, C., Chang, P., Yang, L., Wang, Y., Zhu, S., Shan, H. ... Tao, L. (2018). Neuroprotective effects of hydrogen sulfide on sodium azide-induced oxidative stress in PC12 cells. International Journal of Molecular Medicine, 41, 242-250.
Gao, C., Chang, P., Yang, L., Wang, Y., Zhu, S., Shan, H., Zhang, M., Tao, L."Neuroprotective effects of hydrogen sulfide on sodium azide-induced oxidative stress in PC12 cells". International Journal of Molecular Medicine 41.1 (2018): 242-250.
Gao, C., Chang, P., Yang, L., Wang, Y., Zhu, S., Shan, H., Zhang, M., Tao, L."Neuroprotective effects of hydrogen sulfide on sodium azide-induced oxidative stress in PC12 cells". International Journal of Molecular Medicine 41, no. 1 (2018): 242-250.